Contracts Finder

CM/PHR/23/5701- NHS National Framework for Natalizumab-February 2024

NHS England

Awarded
goods
SME-friendly
Framework agreement

Published on NHS Health Family Atamis procurement portal

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.

Key details

Contracting authority
Region
Runcorn
Delivery: United Kingdom
Contract value
£63,746,000ex VAT
Submissions closed
4 December 2023
Published
2 November 2023

Procurement

Contract period
1 February 2024 - 31 August 2025
2 years
Procedure type
Open procedure (above threshold)
CPV classifications
  • 33600000 Pharmaceutical products

What happened

NHS England awarded this contract to Sandoz Ltd | Biogen worth £63,746,000 on 5 Jan 2024. The contract runs until 31 Aug 2025.

Description

NHS National Framework for Natalizumab - February 2024

Offer reference number: CM/PHR/23/5701

Period of framework: 1 February 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Awarded suppliers (2)

Suppliers
  • Sandoz Ltd
  • Biogen
Award value
£63,746,000
Award date
5 January 2024

Contact

Address
2nd Floor Rutland House, Runcorn, WA7 2ES
Contact name
Katie Noonan

Identifiers

Buyer reference
CF-2152500D0O000000rwimUAA
Notice ID
53f7b78e-75ed-4e96-b6cf-6d9ed4467538-719822
OCID
ocds-b5fd17-af113a3d-7ddb-4c04-91a1-93583069c43a

Explore related tenders

External ID: cf-ocds-b5fd17-af113a3d-7ddb-4c04-91a1-93583069c43a • Added 3 October 2026